Kensington Health   Report issue

Academic/Hospital Phase 3
Founded: Toronto Canada (1954)

Organization Overview

First Clinical Trial
2015
NCT03464240
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Kensington Screening Clinic

Active Ingredients

Drugs in Phase 3 Trials (1)

teduglutide (gattex kit) (1 trial)

Drugs in Other Trials (1)

glucose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperlipidemias (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2